Tuberculosis Elimination Jennifer Flood, MD, MPH Pennan Barry, MD, MPH NAR-NTCA February 25, 2016
|
|
- Posy Thornton
- 5 years ago
- Views:
Transcription
1 Tuberculosis Elimination Jennifer Flood, MD, MPH Pennan Barry, MD, MPH NAR-NTCA February 25, 2016 Picture source:
2 Questions What is the California dream? What is our current reality? Can the dream come true? 2
3 California > 1,000 miles of beach, 1100 surfers 310 days of sunshine, 110 state parks Opportunities: gold rush, free speech, tech boom >200 airports: ports of entry >100 million passengers/yr
4 Population: 39 million > 10 million immigrants ~25% of foreignborn in U.S. ~25% of TB in U.S. From Public Policy Institute of California ( Sources: U.S. Census Bureau Decennial Censuses, American Community Survey, and the Department of Homeland Security. 4
5 CA Tuberculosis Epidemic ,000 10,000 Number of TB Cases Case Rate per 100, years ago 1 in 9 died of TB at age 30 8,000 6,000 4,000 2, TB Cases TB Rate 5
6 Why aren t we satisfied? TB is diagnosed every four hours Every other day a Californian dies with TB Each week at least one child under 5 found to have TB 6
7 Elimination Definitions Status Rate Cases in California* Current (2015) 56 cases/million 2,147 Elimination <1 case / million 39 *Based on 2014 US Census Estimate of California Population: 38.8 million WHO. Framework towards TB Elimination in Low-Incidence Countries
8 Rate per 1 Million Year of TB elimination in California Extrapolation based on current rate of decline* Actual Current decline (-4%) 2040 Elimination (-14%) Elimination Year * Average annual decline in case rate
9 2015: Young Californian with TB disease 28 year old male with TB disease TB caused neck and chest lymph nodes to enlarge around his airway With treatment his lymph nodes may get larger before they resolve He asks: Is there anything he could have done to prevent this from happening? 9
10 Preventing TB 10
11 How do TB Cases Occur in California? 7.5% Importation 835 of 11,149 cases occurred within 1 year of arrival in U.S. ( ) 79.5% Reactivation of remote infection Cases not from importation or recent transmission ~2,100 TB Cases Per Year 13% Recent Transmission CDC plausible source case method* * France et al, Am J Epidemiol
12 Reported TB in California, 2015 Foreign-born 81% US-born 19% Each = 1 TB case (Total = 2137) 12
13 Median Age at Report of TB (years) Median Age of TB Cases by Nativity California US-born Foreign-born
14 Medical Risk Factors Adult TB cases (Age 15+) California or more risk DM, ESRD, HIV, TNF-α, organ transplant, steroids, immunosuppression Total n (%) US-born % Foreign-born % 757 (37%) 23.1% 39.4% Diabetes 585 (28%) 13.6% 31.2%
15 Only ~1/3 of TB Cases are Foreign-Born with Medical Risk (Age 15+) California, 2015 US Born Foreign Born 2,069 TB Cases 780 (38%) 936 (45%) Medical Risk 0% 20% 40% 60% 80% 100% medical risk: current smoking, DM, HIV, ESRD, organ transplant, TNF-alpha, other immunosuppression 15
16 2.1 Million Estimated TB Infections, California 2014 U.S. Born Foreign Born 0.5 Million 1.6 Million 0% 20% 40% 60% 80% 100% Estimated by applying nativity and race/ethnicity-specific TB infection prevalence from NHANES (Miramontes, 2015) to the California CPS population estimates using TST for US born and IGRA for foreign born 16
17 Millions of persons Estimated TB Infection prevalence, awareness, treatment California, 2014 NHANES applied to California population U.S.-born Foreign-born M 20% 12% LTBI prevalence Aware of LTBI Treated for LTBI 17
18 How many Californians are being Group tested for TB Infection now? Estimated Number tested annually TB risk Healthcare workers 1,443,000 Low State prison inmates 130,000 Low Status adjusters (civil surgeon screening) 105,000 HIV infection 18,000 High Contacts 17,000 High Moderate-High Refugees 8,000 Moderate-High B-notification arrivers 5,000 High Very High Others? varied Total 1,726,000 * 18
19 19
20 Risk Assessment For use by primary care providers Influenced by CA TB Elimination Task Force Extensive feedback from diverse providers Simplicity, clarity over detail Companion Fact Sheet Customizable for local programs
21 Who should I test for TB Infection? 21
22 Who should I test for TB Infection? 22
23 23
24 ~90% of Adult TB Cases Would be tested by Risk Assessment (Age 15+) California, 2015 US Born Foreign Born 2,059 TB Cases Covered by California Risk Assessment (88%) 0% 20% 40% 60% 80% 100% medical risk: current smoking, DM, HIV, ESRD, organ transplant, TNF-alpha, other immunosuppression 24
25 Migration to California Persons in U.S. for <1 yr 160, , , ,000 80,000 60,000 40,000 20, Others India Vietnam Philippines China Mexico Source: ACS surveys
26 Why now? Expanded access to care focused on prevention 12 dose regimen has very high completion rates TB transmission at nadir so re-infection unlikely IGRAs can weed out BCG false positives International focus on LTBI contribution to end TB Economic benefit of TB prevention clearer 26
27 Challenges Engage those at risk and their providers? Not all individuals at risk are in care Care delivery system is complex Primary care clinicians overwhelmed Out-of-pocket costs for TB services for some Drug supply not continuous Limited health department resources 27
28 California TB Elimination Task Force Recommendations Insert photo of task force meeting 28
29 Find and engage persons with TB risk and their providers Create epidemiologic profiles of populations at high risk for infection and disease and providers who serve them Ensure foreign birth/ birth country are included in EMR 29
30 85, 731 patients: 81% Hispanic 21% diabetes High % with foreign birth FQHCs: % foreign birth Risk characteristics TB cases 30
31 Apply effective strategies for LTBI testing Focus testing on foreign-born persons Use IGRAs for BCG-vaccinated persons Reduce testing of low-risk persons Update California laws to risk-based testing: teachers, parks and rec workers students, healthcare workers 31
32 Optimize treatment for LTBI Maximize treatment of routinely tested Use shortest effective LTBI treatment and new adherence technologies Civil surgeons to refer/treat status adjusters who test positive for TB infection Jail setting: 9H replaced with 12 dose regimen achieved > 85% treatment completion 32
33 Make TB prevention routine Build strong public/private partnerships Motivate community providers serving key populations to test and treat US Preventive Services Task Force A/B Rating? Create simple messages for providers and public 3 risk groups Implement system to measure and track progress with least burden report LTBI 33
34 North East Medical Services San Francisco, California 62,035 patients: majority from China, uninsured, limited English Account for 5% of SF TB cases each year Focused on young with diabetes, smoking Change process: standing orders, training, provider report cards, auto-reminders for appointments Courtesy of Dr. Jerry Jew (Medical Director, NEMS) 34
35 Courtesy of Dr. Jerry Jew (Medical Director, NEMS) 87.5% 78.3%
36 Remove financial impediments for providers and patients Ensure access to 12 dose regimen on formularies Remove patient share of cost for TB service Letter to Covered California/Medi-Cal Make an serious investment in prevention CA TB Elimination Challenge 2040 Fund Fully appropriate U.S. Comprehensive Elimination Act 36
37 Summary /Next Steps The California dream is a big dream: TB elimination by 2040 Current reality: sluggish decline and preventable TB and deaths We are optimistic dream can come true Focus = prevention (while maintaining strong case detection and rx) Normalize testing and treating high risk populations NEXT STEPS : Elimination Plan will be set into action in 2016! 37
38 2 year old male fever, weight loss, seizures meningitis with brain and lung TB
39 Acknowledgments CA TB Survivors Local TB Control Programs CA TB Controllers Association Curry International TB Center CA TB Control Branch Staff TB Elimination Task Force and Coalition Task Force Report 2015 and CA TB Risk Assessment /tb/pages/default.aspx 39
40 EXTRA SLIDES 40
41 California Dreamin All the leaves are brown (all the leaves are brown) And the sky is grey (and the sky is grey) I've been for a walk (I've been for a walk) On a winter's day (on a winter's day) I'd be safe and warm (I'd be safe and warm) If I was in L.A. (if I was in L.A.) California dreamin' (California dreamin') On such a winter's day The Mamas and the Papas
42 TB Cases in California Testing Foreign Born Interventions Base case (4% tested) Use QFT/3HP 2x testing (FB) 4x testing (FB) ~1.6M 10x testing (FB) Year 42 2x, 4x, 10x use QFT/3HP Dotted lines represent pre-elimination and elimination
43 Newcomers to California Examples Number per year TB screening before entry? TB screening later? New permanent immigrants Immigrants Refugees Nonimmigrant Admissions Tourist/ Business Entries Students Workers No legal status Undocumented 100,000 10,400, ,000? Active Disease No N/A Active and latent 7,000 with abnormal CXR Active and latent 100,000 applying for permanent residency N/A Source: US Dept of Homeland Security. Yearbook of Immigration Statistics
44 Mean Life Expectancy (years) Mean Age and Life Expectancy by risk group Foreign born adults Bubble size=number with LTBI BMI <18.5 All Foreign Born IVDU Adults Alcohol TNF Alpha Tobacco HIV+ Recent SOT Steroids Post SOT Diabetes Heme Cancer ESRD Solid Organ Cancer Mean Age Source: Yeats 2015 RAND Dissertation: Priorities for Targeted Testing for Latent Tuberculosis Infection among Foreign Born Adults in the United States, Table (
45 Medical Risk Factors Adult TB cases (Age 15+) California 2015 Total n (%) US-born % Foreign-born % Diabetes 585 (28%) 13.6% 31.2% ESRD 83 (4%) 2.0% 4.4% HIV positive 62 (3%) 5.2% 2.6% Other immunosuppression Post-organ transplantation 113 (5%) 4.3% 5.7% 9 (0.5%) 0.6% 0.4% TNF-antagonist rx 13 (0.6) 0.6% 0.6% 1 or more risk 757 (37%) 23.1% 39.4%
46 How do TB Cases Occur in California? Importation TB within 1 year of US arrival Recent Transmission CDC plausible source case method Reactivation of remote infection ~2,100 TB Cases Per Year France et al, Am J Epidemiol
47 Rate per 1 Million Years of TB elimination in California Extrapolation based on current rate of decline* Actual Current decline (-4%) 2040 Elimination (-14%) Elimination Year * Average annual decline in case rate
48 Cases per 100,000 TB case rate by nativity California U.S.-born Foreign-born Year
49 Adult Tuberculosis Cases California, , N(%) Total Cases Aged 15 yrs 8482 Foreign Born 6901 (81.4) US Born 1569 (18.5) Recent US arrival <1yr 925 (13.4) RT 450 (6.5) Reactivation 5526 (80) Reactivation 1284 (81.8) RT 285 (18.2) RT = recent transmission Medical risk 2073 (37.5) No medical risk 3453 (62.5) ~1350 smokers also included here No Medical medical risk risk (69) (30.5) Immuno- suppressed 584 (28.2) Not immunosuppressed 1489 (71.8) Medical Risk: Immunosuppressed: HIV, organ transplant, TNF-alpha, other immunosuppression Not immunosuppressed: DM, ESRD Not Immunosuppressed 204 (52.5) Immunosuppressed 187 (47.8)
50 100% Foreign-born Reactivation TB cases Percent without medical risk factor* California, % 60% 40% 20% 0% 94% 89% 72% 54% 52% 50% 53% 57% 65% Age Group *Does not include smoking Total N=
51 Foreign-born Reactivation TB cases Number without medical risk factor* California, Age Group *Does not include smoking Total N=
52 Foreign-born Reactivation TB cases Cumulative percent without medical risk factor* California, % 80% 60% 40% 20% 0% 8% 27% 43% 57% 71% 83% 95% 100% 100% Age Group *Does not include smoking Total N=
53 TB Cases Years in US at TB Diagnosis California, % in US > 5.9 years 50% in US >16 years Median 16.0 yrs 30 25Q Q Q Years in US 53
54 Percent cases Time in US by Country of Origin, < 1 year in US 5+ years in US % % China India Mexico Philippines Vietnam
55 Time in US by Country of Origin, 2015 <1 year 5+ years China 7% 81% India 20% 57% Mexico 6% 89% Philippines 9% 82% Vietnam 8% 79%
56 Immigration Status, 2015 Impact of student and employee overseas screening may not be evident for a few years following implementation. 750 (44%) of foreign-born TB cases entered the US with an immigration visa. 53 (3%) cases had student visas 39 (2%) cases had employee visas Time in US for TB cases entering US with student or employee visa, 2015 Visa Type <1 year 1-2 years 2-5 years 5+ years Student 18 (35%) 6 (12%) 11 (22%) 16 (31%) Employee 6 (16%) 4 (11%) 7 (19%) 19 (53%)
57 Migration to California from 250, , , ,000 50,000 0 Top 5 countries of origin Persons in U.S. for <2 yrs India Vietnam Philippines China Mexico Source: ACS surveys
58 Average population Thousands Foreign born: Years in U.S. California, Years in US 58
59 Average Annual Population (Thousands) Foreign born: Years in U.S. California, China N=797,046 Philippines N=869,649 Vietnam N=511,264 India N=493, <=
60 Average Annual Population (Thousands) Foreign born: Years in U.S. California, Mexico N=4,344, <=1954 Source: ACS surveys 60
61 Mean Life Expectancy (years) Mean Age and Life Expectancy by risk group Foreign born adults BMI <18.5 All Foreign Born IVDU Adults Alcohol TNF Alpha Tobacco HIV+ Recent SOT Steroids Post SOT Diabetes Heme Cancer ESRD Solid Organ Cancer Mean Age Source: Yeats 2015 RAND Dissertation: Priorities for Targeted Testing for Latent Tuberculosis Infection among Foreign Born Adults in the United States, Table 12 61
62 Mean Life Expectancy (years) Mean Age and Life Expectancy by risk group Foreign born adults Bubble size=number with LTBI BMI <18.5 All Foreign Born IVDU Adults Alcohol TNF Alpha Tobacco HIV+ Recent SOT Steroids Post SOT Diabetes Heme Cancer ESRD Solid Organ Cancer Mean Age Source: Yeats 2015 RAND Dissertation: Priorities for Targeted Testing for Latent Tuberculosis Infection among Foreign Born Adults in the United States, Table (
63 Mean Life Expectancy (years) Mean Age and Life Expectancy by risk group Foreign born adults Bubble size=number with LTBI BMI <18.5 IVDU Alcohol TNF Alpha Tobacco HIV+ Recent SOT Steroids Post SOT Diabetes Heme Cancer ESRD Diabetes Average: Age: 59 Life expectancy: 12.5 Lifetime TB risk: 3.4% Solid Organ Cancer Mean Age Source: Yeats 2015 RAND Dissertation: Priorities for Targeted Testing for Latent Tuberculosis Infection among Foreign Born Adults in the United States, Table (
64 Mean Life Expectancy (years) Mean Age and Life Expectancy by risk group 30 Foreign born adults Bubble size=number with LTBI Age Age Age Age Age Age Mean Age Source: Yeats 2015 RAND Dissertation: Priorities for Targeted Testing for Latent Tuberculosis Infection among Foreign Born Adults in the United States, Table 12 64
65 2 5 Y E A R S Modeling TB Elimination Slides courtesy Alex Goodell, Jim Kahn and UCSF/Berkeley/Stanford CAPE Investigators
66 TB Cases in California Testing overall population Interventions Base case (4% tested) Use QFT/3HP 2x testing (all) 4x testing (all) ~6.8M 10x testing (all) 2x, 4x, 10x use QFT/3HP Dotted line represent elimination Year Estimated with 10x testing: 64 cases / year Elimination: 59 cases / year
67 Selected TB Prevention Activities in California 67
TB-Free California: How close are we? How can we get closer?
TB-Free California: How close are we? How can we get closer? California TB Controllers Association April 21, 2015 Pennan Barry, MD, MPH Chief, Surveillance and Epidemiology Section Acknowledgments Local
More informationPediatric Tuberculosis in Los Angeles County: An Update
Pediatric Tuberculosis in Los Angeles County: An Update Julie Higashi, MD PhD Director, Tuberculosis Control Program March 2, 2019 0 Pediatricians will be the driving force of TB elimination in California
More informationTB EPIDEMIOLOGY. Outline. Estimated Global TB Burden, TB epidemiology
TB EPIDEMIOLOGY TB Clinical Intensive Course Curry International Tuberculosis Center September 30, 2015 Varsha Nimbal, MPH Tuberculosis Control Branch California Department of Public Health 1 Outline TB
More informationExpanding Latent Tuberculosis Infection Testing and Treatment to Accelerate Tuberculosis Elimination
IUATLD North American Region Conference February 24, 2017 Vancouver, BC Expanding Latent Tuberculosis Infection Testing and Treatment to Accelerate Tuberculosis Elimination Philip LoBue, MD National Center
More informationTuberculosis Epidemiology
Tuberculosis Epidemiology TB CLINICAL INTENSIVE COURSE Curry International Tuberculosis Center October 18, 2017 Varsha Hampole, MPH Tuberculosis Control Branch California Department Of Public Health Outline
More informationTB Intensive Minneapolis, Minnesota September 23-26, 2008
TB Intensive Minneapolis, Minnesota September 23-26, 2008 TB in the Foreign-Born Population: Background and Demographic Overview Marge Higgins, LSW September 24, 2008 TB in the Foreign-Born Population
More informationTB Infection Who is Testing and Treating? TB Control and Elimination: Current Dilemma. Span of TB Control: 2010
TB Infection Who is Testing and Treating? Jennifer Flood, M.D., M.P.H. California Department of Public Health Tuberculosis Control Branch Jennifer.Flood@cdph.ca.gov 1 TB Control and Elimination: Current
More informationLatent Tuberculosis Infection Reporting Instructions for Civil Surgeons Using CalREDIE Provider Portal
Latent Tuberculosis Infection Reporting Instructions for Civil Surgeons Using CalREDIE Provider Portal Civil surgeons are required to report tuberculosis (TB) screening outcomes that result in latent TB
More informationTuberculosis in Alameda County, 2012
Tuberculosis in Alameda County, 212 Alameda County Public Health Department Tuberculosis Overview Tuberculosis (TB) is a preventable and curable disease that remains one of the leading causes of death
More informationTB in California: Costs, Transmission, and Selecting from the Latent Pool
TB in California: Costs, Transmission, and Selecting from the Latent Pool Pennan Barry, MD, MPH Tuberculosis Control Branch California Department of Public Health California Tuberculosis Controller s Association
More informationTuberculosis in Alameda County, 2009
Tuberculosis in Alameda County, 29 Alameda County Public Health Department Tuberculosis Overview Tuberculosis (TB) is a communicable disease caused by the bacteria Mycobacterium tuberculosis. TB is spread
More informationDiagnosis Latent Tuberculosis. Disclosures. Case
Diagnosis Latent Tuberculosis Neha Shah MD MPH Field Medical Officer Tuberculosis Control Branch California Department of Public Health Centers for Disease Control and Prevention September 2016 1 Disclosures
More informationTuberculosis in Alameda County, 2014 Alameda County Public Health Department
Tuberculosis in Alameda, 214 Alameda Public Health Department Tuberculosis (TB) is a preventable and curable disease that remains one of the leading causes of death worldwide. TB is a communicable disease
More informationDisclosures. Updates in TB for the PCP: Opportunities for Prevention. Objectives PART 1: WHY TEST? 4/14/2016. None
Disclosures Updates in TB for the PCP: Opportunities for Prevention None Pennan Barry, MD, MPH Chief, Surveillance and Epidemiology, California TB Control Branch Assistant Clinical Professor, Division
More informationTuberculosis Populations at Risk
Tuberculosis Populations at Risk One-third of the world is infected with TB, an average of one new infection per second Two million people died from tuberculosis in 2010, 1 every 20 seconds TB is the leading
More informationThe Tip of the Iceberg: Addressing Latent Tuberculosis Infection to Accelerate Tuberculosis Elimination
Four Corners TB and HIV Conference November 3, 2015 Durango, CO The Tip of the Iceberg: Addressing Latent Tuberculosis Infection to Accelerate Tuberculosis Elimination Philip LoBue, MD National Center
More information4/25/2012. The information on patterns of infection and disease can assist in: Assessing current and evolving trends in TB
Sindy M. Paul, MD, MPH, FACPM May 1, 2012 The information on patterns of infection and disease can assist in: Assessing current and evolving trends in TB morbidity, including resistance Identifying people
More informationRevised Technical Instructions for Civil Surgeons. October 9, 2018
Revised Technical Instructions for Civil Surgeons October 9, 2018 Speakers Joanna Regan Centers for Disease Control and Prevention Shereen Katrak California Department of Public Health Pennan Barry California
More informationPlease distribute a copy of this information to each provider in your organization.
HEALTH ADVISORY TO: Physicians and other Healthcare Providers Please distribute a copy of this information to each provider in your organization. Questions regarding this information may be directed to
More informationLTBI: Who to Test & When to Treat
LTBI: Who to Test & When to Treat TB Intensive May 10 th, 2016 David Horne, MD, MPH Harborview Medical Center University of Washington DISCLOSURES I have no disclosures or conflicts of interest to report
More informationUpdate on the 2007 TB Technical Instructions. Adriene Rister TB Control Coordinator Mainely TB: April 14, 2011
Update on the 2007 TB Technical Instructions Adriene Rister TB Control Coordinator Mainely TB: April 14, 2011 Annual Estimate of Migrants Entering the U.S. Refugees: 50,000-70,000 Immigrants: ~1 million
More information2016 Annual Tuberculosis Report For Fresno County
206 Annual Tuberculosis Report For Fresno County Cases Rate per 00,000 people 206 Tuberculosis Annual Report Fresno County Department of Public Health (FCDPH) Tuberculosis Control Program Tuberculosis
More informationLatent Tuberculosis Best Practices
Latent Tuberculosis Best Practices Last Updated September 7, 2016 LTBI Demographics in the US o 13million people in the US with LTBI (estimate) o In 2014, approximately 66% of TB cases in the United States
More informationCalifornia TB program updates
California TB program updates CAPHLD Conference Nov 6, 2017 Pennan Barry, M.D., M.P.H. Chief, Surveillance and Epidemiology Section Lead MD, California MDR TB Service pennan.barry@cdph.ca.gov Outline California
More informationDetection and Treatment of Tuberculosis in Correctional Facilities: Opportunities and Challenges
Detection and Treatment of Tuberculosis in Correctional Facilities: Opportunities and Challenges David Karol, MD, MA Bureau of Prisons, FMC Butner Duke University Medical Center June 26, 2013 No Disclosures
More informationTuberculosis in Alameda County, 2011
Tuberculosis in Alameda County, 211 Alameda County Public Health Department Tuberculosis Overview Tuberculosis (TB) is a preventable and curable disease that remains one of the leading causes of death
More information10/3/2017. Updates in Tuberculosis. Global Tuberculosis, WHO 2015 report. Objectives. Disclosures. I have nothing to disclose
Disclosures Updates in Tuberculosis I have nothing to disclose Chris Keh, MD Assistant Clinical Professor, Division of Infectious Diseases, UCSF TB Controller, TB Prevention and Control Program, Population
More informationThe Public Health Impact of TB in the Correctional System. Sarah Bur, RN, MPH Federal Bureau of Prisons Infection Prevention and Control Officer
The Public Health Impact of TB in the Correctional System Sarah Bur, RN, MPH Federal Bureau of Prisons Infection Prevention and Control Officer The Public Health Impact of TB in the Correctional System
More informationTuberculosis Elimination
Tuberculosis Elimination Where We ve Been, Where We re Going Mark Lobato, MD New England TB Consultant Division of Tuberculosis Elimination Centers for Disease Control and Prevention Disclosures / Disclaimer
More informationThe Epidemiology of Tuberculosis in Minnesota,
The Epidemiology of Tuberculosis in Minnesota, 2011 2015 Minnesota Department of Health Tuberculosis Prevention and Control Program (651) 201-5414 Tuberculosis surveillance data for Minnesota are available
More informationTUBERCULOSIS CONTACT INVESTIGATION
TB CASE MANAGEMENT AND CONTACT INVESTIGATION INTENSIVE TUBERCULOSIS CONTACT INVESTIGATION LEARNING OBJECTIVES Upon completion of this session, participants will be able to: 1. Describe the criteria used
More informationTUBERCULOSIS IN HEALTHCARE SETTINGS Diana M. Nilsen, MD, FCCP Director of Medical Affairs, Bureau of Tuberculosis Control New York City Department of
TUBERCULOSIS IN HEALTHCARE SETTINGS Diana M. Nilsen, MD, FCCP Director of Medical Affairs, Bureau of Tuberculosis Control New York City Department of Health and Mental Hygiene TODAY S PRESENTATION Epidemiology
More informationThe American Experience with TB Elimination
Reaching the Goal of TB Elimination by 2035 March 3, 2015 The American Experience with TB Elimination John Jereb, M.D. Medical officer Division of Tuberculosis Elimination National Center for HIV/AIDS,
More informationOutline. Tuberculosis (TB) Medical Evaluation for TB 5/5/2014. Chest Radiograph with Lower Lobe Cavity
Jean Beinemann RN, Terri Boxrucker RN, and LT Dee Dee Downie MPH Outline The disease The outbreak The response The conclusions May 18, 2014 Wisconsin Public Health Association Annual Meeting Tuberculosis
More information2014 Annual Report Tuberculosis in Fresno County. Department of Public Health
214 Annual Report Tuberculosis in Fresno County Department of Public Health www.fcdph.org Tuberculosis (TB) is a common communicable disease caused by the bacterium Mycobacterium tuberculosis and occasionally
More informationMycobacterial Infections: What the Primary Provider Should Know about Tuberculosis
Mycobacterial Infections: What the Primary Provider Should Know about Tuberculosis Henry F. Chambers, M.D Professor of Medicine, UCSF Topics for Discussion Epidemiology Diagnosis of active TB Screening
More informationDisclosures. TB and CoMorbidities Challenges and Opportunities. Burden of TB. Outline of the lecture. Target testing for TB Infection TB HIV 3/25/2012
Disclosures TB and CoMorbidities Challenges and Opportunities E. Jane Carter, M.D. Associate Professor of Medicine Alpert School of Medicine, Brown University Providence, Rhode Island No financial disclosures
More informationMonitoring & evaluation LTBI management in the Netherlands. Key lessons.
Monitoring & evaluation LTBI management in the Netherlands. Key lessons. Gerard de Vries, MD MSc PhD, Coordinator TB control the Netherlands, KNCV Tuberculosis Foundation/RIVM-CIb Global WHO Consultation
More informationLatent TB Infection (LTBI) Strategies for Detection and Management
Latent TB Infection (LTBI) Strategies for Detection and Management Patrick T. Dowling MD,MPH Professor and Chair Dept of Family Medicine David Geffen School of Medicine at UCLA Pri-Med March 29 2014 Pdowling@mednet.ucla.edu
More informationArizona Annual Tuberculosis Surveillance Report
Arizona Annual Tuberculosis Surveillance Report 2014 Table of Contents I. Executive Summary 1 II. Case Rates 3 III. Cases and Case Rates by Race and Ethnicity 4 IV. Cases by Gender 4 V. Cases and Case
More informationTuberculosis Screening and Targeted Testing of College and University Students: Developing a Best Practice Approach:
Tuberculosis Screening and Targeted Testing of College and University Students: Developing a Best Practice Approach: Lori A. Soos MA, BSN, RN, Niagara University Deborah Penoyer, MS, RN, SUNY Geneseo Learning
More informationTuberculosis and Diabetes Mellitus. Lana Kay Tyer, RN MSN WA State Department of Health TB Nurse Consultant
Tuberculosis and Diabetes Mellitus Lana Kay Tyer, RN MSN WA State Department of Health TB Nurse Consultant Learning Objectives Understand the impact of uncontrolled diabetes mellitus (DM) on TB infection
More informationWASHINGTON STATE COMMUNICABLE DISEASES OF PUBLIC HEALTH SIGNIFICANCE FOR THE CIVIL SURGEON
WASHINGTON STATE COMMUNICABLE DISEASES OF PUBLIC HEALTH SIGNIFICANCE FOR THE CIVIL SURGEON SCOTT LINDQUIST MD MPH WASHINGTON STATE DEPARTMENT OF HEALTH STATE EPIDEMIOLOGIST FOR COMMUNICABLE DISEASES FOREIGN-BORN
More informationTB Classification (ATS/CDC)
bits and pieces Lisa Chen, MD UCSF Pulmonary/Critical Care Curry International Tuberculosis Center 10/2017 TB Classification (ATS/CDC) TB0 No tuberculosis exposure, not infected TB1 Tuberculosis exposure,
More informationTuberculosis & Refugees in Philadelphia
Tuberculosis & Refugees in Philadelphia Philadelphia TB Control Program Daniel P. Dohony, MPH Philadelphia TB Control Program Health Information Portal Website: hip.phila.gov Contains Information On» Disease
More informationProgrammatic management of LTBI : a two pronged approach for ending the TB epidemic. Haileyesus Getahun Global TB Programme WHO/HQ
Programmatic management of LTBI : a two pronged approach for ending the TB epidemic Haileyesus Getahun Global TB Programme WHO/HQ What is latent TB infection? A state of persistent immune response to stimulation
More informationLATENT TUBERCULOSIS. Robert F. Tyree, MD
LATENT TUBERCULOSIS Robert F. Tyree, MD 1 YK TB OFFICERS Ron Bowerman Elizabeth Roll Mien Chyi (Pediatrics) Cindi Mondesir (Pediatrics) The new guys: Philip Johnson Robert Tyree 2009 CDC TB CASE DEFINITION
More informationTB: Management in an era of multiple drug resistance. Bob Belknap M.D. Denver Public Health November 2012
TB: Management in an era of multiple drug resistance Bob Belknap M.D. Denver Public Health November 2012 Objectives: 1. Explain the steps for diagnosing latent and active TB role of interferon-gamma release
More informationThese recommendations will remain in effect until the national shortage of PPD solution has abated.
Maryland Recommendations Regarding the National Shortage of Purified Protein Derivative (PPD) Solution; Attachment to Health Officer Memorandum National Shortages of Tubersol and Aplisol for TB Skin Testing;
More informationGlobal, National, Regional
Epidemiology of TB: Global, National, Regional September 13, 211 Edward Zuroweste, MD Chief Medical Officer Migrant Clinicians Network Assistant Professor of Medicine Johns Hopkins School of Medicine Epidemiology
More informationEvaluation and Management of the Patient with Latent Tuberculosis Infection (LTBI)
Evaluation and Management of the Patient with Latent Tuberculosis Infection (LTBI) CURTIS FOWLER MPT,PA C ASSISTANT CLINICAL PROFESSOR UNIVERSITY OF THE PACIFIC Learning objectives Recognize the appropriate
More informationCHILDHOOD TUBERCULOSIS: NEW WRINKLES IN AN OLD DISEASE [FOR THE NON-TB EXPERT]
CHILDHOOD TUBERCULOSIS: NEW WRINKLES IN AN OLD DISEASE [FOR THE NON-TB EXPERT] QUESTION: : Which children in the United States should get a tuberculin skin test? Do questionnaires really work? Jeffrey
More informationTB Nurse Case Management San Antonio, Texas July 18 20, 2012
TB Nurse Case Management San Antonio, Texas July 18 20, 2012 TB Epidemiology Robert Petrossian July 18, 2012 Robert Petrossian has the following disclosures to make: No conflict of interests No relevant
More informationTB trends and TB genotyping
Management of a TB Contact Investigation for Public Health Workers Albuquerque, NM October 1, 214 TB trends and TB genotyping Marcos Burgos MD October 1, 214 Marcos Burgos, MD has the following disclosures
More informationTB 2015 burden, challenges, response. Dr Mario RAVIGLIONE Director
TB 2015 burden, challenges, response Dr Mario RAVIGLIONE Director Addis Ababa, Ethiopia 11-13 November 2015 Overview TB basics TB burden & challenges Response: End TB Strategy DAY 1 What is TB? Definition
More informationTuberculosis Tools: A Clinical Update
Tuberculosis Tools: A Clinical Update CAPA Conference 2014 JoAnn Deasy, PA-C. MPH, DFAAPA jadeasy@sbcglobal.net Adjunct Faculty Touro PA Program Learning Objectives Outline the pathogenesis of active pulmonary
More informationTB is Global. Latent TB Infection (LTBI) Sharing the Care: Working Together. September 24, 2014
Sharing the Care: Working Together to Meet the Challenge of TB Presented by: Barbara Cole, RN, PHN, MSN Director, Disease Control County of Riverside Department of Public Health Curry International TB
More informationContact Investigation
Tuberculosis Ann Raftery, RN, PHN, MSc GHS Learning Objectives Upon completion of this session, participants will be able to: Describe the criteria used and method for determining the infectious period
More information2015 Annual Report Tuberculosis in Fresno County. Department of Public Health
215 Annual Report Tuberculosis in Fresno County Department of Public Health www.fcdph.org Number of Cases Rate per 1, Population 215 Tuberculosis Annual Report Fresno County Department of Public Health
More informationGlobal, National, Regional
Epidemiology of TB: Global, National, Regional September 13, 211 Edward Zuroweste, MD Chief Medical Officer Migrant Clinicians Network Assistant Professor of Medicine Johns Hopkins School of Medicine Epidemiology
More information11/1/2017. Disclosures. Update In Tuberculosis, Indiana Outline/Objectives. Pathogenesis of M.tb Global/U.S. TB Burden, 2016
Disclosures Update In Tuberculosis, Indiana 2017 Bradley Allen, MD, PhD, FACP, FIDSA Indiana University School of Medicine Division of Infectious Diseases Roudebush VAMC Indianapolis Medical Consultant,
More informationGuidance for Identifying Risk Factors for Mycobacterium tuberculosis (MTB) During Evaluation of Potential Living Kidney Donors
Summary and Goals On November 13, 2012, the OPTN/UNOS Board of Directors approved a requirement that all potential living kidney donors undergo evaluation for infection with Mycobacterium tuberculosis
More informationContact Investigation and Prevention in the USA
Contact Investigation and Prevention in the USA George D. McSherry, MD Division of Infectious Disease Penn State Children s Hospital Pediatric Section TB Center of Excellence Rutgers Global Tuberculosis
More informationTB in Foreign Born and High Risk Populations
TB Nurse Case Management San Antonio, Texas December 8-10, 2009 TB in Foreign Born and High Risk Populations John J. Nava, M.D. December 9, 2009 Tuberculosis in High Risk Populations and the Foreign Born
More information2013 Annual Report Tuberculosis in Fresno County. Department of Public Health
2013 Annual Report Tuberculosis in Fresno County Department of Public Health www.fcdph.org In 2013, provisional data indicates that tuberculosis (TB) affected 3.0 / 100,000 people in the United States
More informationLATENT TUBERCULOSIS SCREENING AND TREATMENT:
LATENT TUBERCULOSIS SCREENING AND TREATMENT: TB or not TB Christopher Kwong, MD and William Rifkin, MD Week 14 Educational Objectives: 1. Understand who should be screened for latent TB infection and why
More informationTuberculosis Among Children in the Republic of the Marshall Islands
Tuberculosis Among Children in the Republic of the Marshall Islands Sarah Labuda, MD, MPH Medical Consultant Meeting San Antonio, TX November 29-30, 2018 1 EXCELLENCE EXPERTISE INNOVATION Disclosures Sarah
More informationLatent Tuberculosis Infections Controversies in Diagnosis and Management Update 2016
Latent Tuberculosis Infections Controversies in Diagnosis and Management Update 2016 Randy Culpepper, MD, MPH Deputy Heath Officer/Medical Director Frederick County Health Department March 16, 2016 2 No
More informationState of the State in TB Control
State of the State in TB Control Jason Stout, MD, MHS Wake County TB Medical Consultant NC TB Medical Director Division of Infectious Diseases, Duke University Medical Center Disclosures-Funding NIH (grant)
More informationLTBI monitoring and evaluation in the Netherlands
LTBI monitoring and evaluation in the Netherlands 17 th Wolfheze Workshops 2015, Den Haag Connie Erkens MD MPH Senior TB consultant Content presentation Epidemiology Target groups for programmatic LTBI
More informationYakima Health District BULLETIN
Yakima Health District BULLETIN Summary Volume 13, Issue 1 February, 2014 Tuberculosis in Yakima County The rate of active tuberculosis (TB) in Yakima County has declined by about two-thirds over the past
More informationInterferon Gamma Release Assay Testing for Latent Tuberculosis Infection: Physician Guidelines
Interferon Gamma Release Assay Testing for Latent Tuberculosis Infection: Physician Guidelines Historically, Latent Tuberculosis Infection (LTBI) diagnosis was based on risk assessment, chest x-ray (CXR)
More informationTuberculosis: Where Are We Now?
Tuberculosis: Where Are We Now? Amee Patrawalla MD MPH Rutgers - NJ Medical School Global TB Institute Rutgers, The State University of New Jersey Learning Objectives Understand the current epidemiologic
More informationEssential Mycobacteriology Laboratory Services in the Era of MDR- and XDR-TB: A TB Controller s Perspective
Essential Mycobacteriology Laboratory Services in the Era of MDR- and XDR-TB: A TB Controller s Perspective James Watt, MD, MPH Acting Chief, Tuberculosis Control Branch California Department of Public
More informationApproaches to LTBI Diagnosis
Approaches to LTBI Diagnosis Focus on LTBI October 8 th, 2018 Michelle Haas, M.D. Associate Director Denver Metro Tuberculosis Program Denver Public Health DISCLOSURES I have no disclosures or conflicts
More informationTB in Prisons and Jails Albuquerque, New Mexico November 28, 2012
TB in Prisons and Jails Albuquerque, New Mexico November 28, 2012 Challenges of TB Treatment in Special Populations in Corrections Marcos Burgos, MD November 28, 2012 Marcos Burgos, MD has the following
More informationPediatric TB Lisa Armitige, MD, PhD September 28, 2011
TB Nurse Case Management Davenport, Iowa September 27 28, 2011 Pediatric TB Lisa Armitige, MD, PhD September 28, 2011 Lisa Armitige, MD, PhD has the following disclosures to make: No conflict of interest.
More informationThe WHO END-TB Strategy
ENDING TB and MDR-TB The WHO END-TB Strategy Dr Mario RAVIGLIONE Director Joint GDI/GLI Partners Forum WHO Geneva, 27 April 2015 This talk will deal with TB Burden Progress, Challenges Way Forward Who
More informationPreventing Tuberculosis (TB) Transmission in Ambulatory Surgery Centers. Heidi Behm, RN, MPH TB Controller HIV/STD/TB Program
Preventing Tuberculosis (TB) Transmission in Ambulatory Surgery Centers Heidi Behm, RN, MPH TB Controller HIV/STD/TB Program Topics of Discussion TB Overview Epidemiology of TB in Oregon Annual Facility
More informationCommunity pharmacy-based tuberculosis skin testing
Community pharmacy-based tuberculosis skin testing Shanna K. O Connor, PharmD ISU KDHS Spring CE Seminar 2018 In support of improving patient care, Idaho State University Kasiska Division of Health Sciences
More informationMEMORANDUM. Re: Guidance for follow-up of newly-arrived individual with Class B1 Tuberculosis Pulmonary Tuberculosis, no treatment
MEMORANDUM To: From: Local Board of Health John Bernardo, MD, Tuberculosis Medical Officer Jennifer Cochran, MPH, Division Director Division of Global Populations and Infectious Disease Prevention Bureau
More informationManagement of Pediatric Tuberculosis in New Jersey
Management of Pediatric Tuberculosis in New Jersey Helen Aguila, MD NJMS Global TB Institute December 15, 2011 This presentation is in part adapted from Pediatric Tuberculosis by Ann Loeffler, MD : Francis
More informationTB Prevention Who and How to Screen
TB Prevention Who and How to Screen 4.8.07. IUATLD 1st Asia Pacific Region Conference 2007 Dr Cynthia Chee Dept of Respiratory Medicine / TB Control Unit Tan Tock Seng Hospital, Singapore Cycle of Infection
More informationCalifornia Colon Cancer Control Program (CCCCP)
California Colon Cancer Control Program (CCCCP) Diane Keys, CCCCP Program Director Chronic Disease Control Branch MISSION OF THE CALIFORNIA DEPARTMENT OF PUBLIC HEALTH Dedicated to optimizing the health
More informationUnderstanding and Managing Latent TB Infection Arnold, Missouri October 5, 2010
Understanding and Managing Latent TB Infection Arnold, Missouri October 5, 2010 What is Latent TB Infection (LTBI)? Traci Hadley, RN October 5, 2010 LTBI or TB Disease? Presented by : Traci Hadley, RN
More informationTuberculosis Exposure, Infection, and Disease Among Children with Medical Comorbidities
Tuberculosis Exposure, Infection, and Disease Among Children with Medical Comorbidities Andrea T. Cruz, MD, MPH, Omar Merchant, Affan Zafar, and Jeffrey R. Starke, MD Department of Pediatrics February
More informationFundamentals of Tuberculosis (TB)
TB in the United States Fundamentals of Tuberculosis (TB) From 1953 to 1984, reported cases decreased by approximately 5.6% each year From 1985 to 1992, reported cases increased by 20% 25,313 cases reported
More informationManagement of Patients with TB Infection Catalina Navarro, RN, BSN April 7, 2015
Management of Patients with TB Infection Catalina Navarro, RN, BSN April 7, 2015 Tuberculosis Infection Diagnosis and Treatment April 7, 2015 El Paso, TX EXCELLENCE EXPERTISE INNOVATION Catalina Navarro,
More informationU.S. Preventive Services Task Force Recommendation Statement: Screening for Latent Tuberculosis Infection (LTBI) in Adults
National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention U.S. Preventive Services Task Force Recommendation Statement: Screening for Latent Tuberculosis Infection (LTBI) in Adults Centers
More informationLatent tuberculosis infection
EXECUTIVE SUMMARY Latent tuberculosis infection Updated and consolidated guidelines for programmatic management Executive summary Latent tuberculosis infection (LTBI) is defined as a state of persistent
More informationState Of Tuberculosis Elimination in the United States, 2017
National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention State Of Tuberculosis Elimination in the United States, 2017 Philip LoBue, MD Director, Division of Tuberculosis Elimination Congressional
More informationTB Intensive Houston, Texas. Childhood Tuberculosis Kim Connelly Smith. November 12, 2009
TB Intensive Houston, Texas November 10-12, 12 2009 Childhood Tuberculosis Kim Connelly Smith MD, MPH November 12, 2009 Childhood Tuberculosis Kim Connelly Smith MD, MPH November 12, 2009 1 OUTLINE Stages
More informationOverview of Contact Investigation Guidelines
Overview of Contact Investigation Guidelines Jessica Quintero, M.Ed. TB Contact Investigation 101 May 4-5, 2016 Little Rock, AR EXCELLENCE EXPERTISE INNOVATION Jessica Quintero, M.Ed. has the following
More informationReport on Tuberculosis in California, 2012
Golden Gate University School of Law GGU Law Digital Commons California Agencies California Documents 2012 Report on Tuberculosis in California, 2012 California Department of Public Health Follow this
More informationJennifer Lam MPH candidate 2009 Johns Hopkins Bloomberg School of Public Health. Preceptors: Wendy Cronin, PhD MT(ASCP), Cathy Goldsborough, RN
Jennifer Lam MPH candidate 2009 Johns Hopkins Bloomberg School of Public Health Preceptors: Wendy Cronin, PhD MT(ASCP), Cathy Goldsborough, RN Phase Symposium: May 6, 2009 Background & Rationale Maryland
More informationInterpretation of TST & IGRA results. Objectives
Interpretation of TST & IGRA results Randall Reves, MD, MSc Volunteer Clinician Denver Metro TB Program and Division of Infectious Diseases, Department of Medicine University of Colorado Denver Objectives
More informationNguyen Van Hung (NTP, Viet Nam)
Technical Consultation Meeting on the Programmatic Management of Latent Tuberculosis Infection 31 August-1 September 2017, Seoul, Republic Korea Adopting new LTBI diagnostics at country level: perspective
More informationMEMORANDUM. Re: Guidance for follow-up of newly-arrived Individual with a Class B1 Tuberculosis Extrapulmonary Tuberculosis
MEMORANDUM To: From: Local Board of Health John Bernardo, MD, Tuberculosis Medical Officer Jennifer Cochran, MPH, Division Director Division of Global Populations and Infectious Disease Prevention Bureau
More informationTB In Detroit 2011* Early TB: Smudge Sign. Who is at risk for exposure to or infection with TB? Who is at risk for TB after exposure or infection?
Those oral antibiotics are just not working! Inpatient Standards of Care & Discharge Planning S/He s in the Hospital: Now What Do I Do? Dana G. Kissner, MD TB Intensive Workshop, Lansing, MI 2012 Objectives:
More information